A new study increases max-dose guidance for semaglutide. This offers hope for those who didn’t reach their weight goals. The ...
Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of diabetes and obesity, while also delivering other health benefits, such as ...
A battle over how to treat childhood obesity is brewing between those in favour and others who warn of the effects on growing bodies ...
Innogen, a Shanghai-based medical technology company, announced that its independently developed, human-derived, ...
Hosted on MSN9h
Big Pharma’s Worst Nightmare or a Total Ripoff? The Truth About Hims’ Cheap Weight Loss PlansHims is a US-based telehealth company offering online prescription medication, over-the-counter drugs, and personal care ...
As Ozempic use rises, some patients report unexpected nasal symptoms, prompting researchers to investigate this new and unusual side effect.
If walking is becoming difficult and physio isn’t working, cutting-edge treatments could be the next step. But which ones are ...
Foresee Pharmaceuticals (TPEx: 6576) ("Foresee") announced today the acceptance of an abstract for presentation at the prestigious American Society of Clinical Oncology, Genitourinary (ASCO-GU) ...
Dr Craig Koniver, a family physician in Charleston, South Carolina, said he currently has 200 patients using the same method ...
Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...
Polycystic ovary syndrome PCOS is a hormonal condition that affects women of reproductive age Read this article to know what ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results